Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
TT-00434
i
Other names:
TT-00434
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
TransThera Biosci
Drug class:
FGFR1 inhibitor, FGFR2 inhibitor, FGFR3 inhibitor
Related drugs:
‹
erdafitinib (70)
surufatinib (7)
Max-40279 (2)
amlexanox (1)
HMPL-453 (1)
BMS-582664 (1)
ASP5878 (0)
FP-1039 (0)
HH185 (0)
LY2874455 (0)
OM-RCA-01 (0)
R1530 (0)
S-49076 (0)
SKI-G-801 (0)
RLY-4008 (3)
ABSK061 (0)
CGT4859 (0)
DS-1123 (0)
RPT835 (0)
PBI-05204 (0)
B-701 (2)
TYRA-300 (1)
FPI-1966 (0)
LY3866288 (0)
R3Mab (0)
erdafitinib (70)
surufatinib (7)
Max-40279 (2)
amlexanox (1)
HMPL-453 (1)
BMS-582664 (1)
ASP5878 (0)
FP-1039 (0)
HH185 (0)
LY2874455 (0)
OM-RCA-01 (0)
R1530 (0)
S-49076 (0)
SKI-G-801 (0)
RLY-4008 (3)
ABSK061 (0)
CGT4859 (0)
DS-1123 (0)
RPT835 (0)
PBI-05204 (0)
B-701 (2)
TYRA-300 (1)
FPI-1966 (0)
LY3866288 (0)
R3Mab (0)
›
Associations
(1)
News
Trials
Filter by
Latest
12ms
Study of the of the Safety and Tolerability of TT-00434 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
P1, N=11, Completed, TransThera Sciences (Nanjing), Inc. | Recruiting --> Completed | N=20 --> 11 | Trial completion date: Dec 2022 --> Oct 2023 | Trial primary completion date: Aug 2022 --> Oct 2023
12 months ago
Trial completion • Enrollment change • Trial completion date • Trial primary completion date • Metastases
|
TT-00434
1year
First-in-human phase I study of TT-00434, an orally available FGFR (1-3) inhibitor in patients with advanced solid tumors (ESMO Asia 2023)
The preliminary antitumor activity was observed in pt with FGFR2 altered cholangiocarcinoma. Further evaluation of the efficacy and safety of TT-00434 in solid tumors with FGFR1-3 alterations is encouraged.
1 year ago
Clinical • P1 data • Metastases
|
FGFR2 (Fibroblast growth factor receptor 2) • FGFR (Fibroblast Growth Factor Receptor)
|
FGFR2 fusion
|
TT-00434
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login